University of Central Florida Music Study (NCT07306065) | Clinical Trial Compass
CompletedNot Applicable
University of Central Florida Music Study
United States80 participantsStarted 2025-08-28
Plain-language summary
The purpose of this study is to scientifically validate the impact of music therapy on Alzheimer's disease (AD) by analyzing molecular biomarkers in salivary exosomes. Exosomes are extracellular vesicles that carry molecular signals from brain cells, providing a non-invasive method to assess physiological changes.
Who can participate
Age range
50 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 50 years old or older.
* 20 adults with no mild-cognitive impairment
* 20 adults with mild-cognitive impairment
* 20 adults with Alzheimer's disease/ dementia.
* participant or the participant's legally authorized representative must be able to read or speak English and agree to comply with study procedures.
* pregnant women may chose to participate
Exclusion Criteria:
* 49 years and younger
* prisoners
* unable to understand English and provide consent
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial studied how music therapy affects Alzheimer's patients by analyzing salivary exosomes — can you explain what salivary exosomes are and what changes researchers were likely hoping to find?
2Since this trial has already been completed, would you be able to help me find out if the results have been published, and what they might mean for whether music therapy could be worth trying as part of my loved one's care?
3This was listed as a non-drug, non-invasive study involving music therapy — do you think music therapy is something we should be incorporating now alongside standard Alzheimer's treatment, regardless of what this trial found?
4Because this study is Phase NA, it sounds more like an observational or exploratory study rather than a treatment trial — does that mean the goal was more about understanding biological signals than proving music therapy works, and how does that affect how we should interpret any results?
5Are there other completed or ongoing trials on music therapy or non-pharmacological approaches for Alzheimer's that you think would be more directly relevant to our situation right now?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Effect of music therapy in Alzheimer's patients by analyzing salivary exosomes